Fast Purification of Recombinant Monomeric Amyloid-β from and Amyloid-β-mCherry Aggregates from Mammalian Cells.

ACS Chem Neurosci

Chemical Engineering and Biotechnology, University of Cambridge, Philippa Fawcett Drive, Cambridge, CB3 0AS, United Kingdom.

Published: October 2020

The Alzheimer's disease related peptide, Amyloid-beta (Aβ)1-40 and 1-42, has proven difficult to be purified as a recombinant monomeric protein due its expression in leading to the formation of insoluble inclusion bodies and its tendency to quickly form insoluble aggregates. A vast array of methods have been used so far, yet many have pitfalls, such as the use of tags for ease of Aβ isolation, the formation of Aβ multimers within the time frame of extraction, or the need to reconstitute Aβ from a freeze-dried state. Here, we present a rapid protocol to produce highly pure and monomeric recombinant Aβ using a one-step ion exchange purification method and to label the peptide using a maleimide dye. The washing, solubilization, and purification steps take only 3 h. We also present a protocol for the isolation of Aβ-mCherry from mammalian cells.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581289PMC
http://dx.doi.org/10.1021/acschemneuro.0c00300DOI Listing

Publication Analysis

Top Keywords

recombinant monomeric
8
mammalian cells
8
fast purification
4
purification recombinant
4
monomeric amyloid-β
4
amyloid-β amyloid-β-mcherry
4
amyloid-β-mcherry aggregates
4
aggregates mammalian
4
cells alzheimer's
4
alzheimer's disease
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!